Sign in to view content

Foveal Capillary Perfusion Density Decreases in Diabetics with DME Treated on a Fixed Regimen of Intravitreal Aflibercept Injections Over 24 Months

Brittney Statler, MD

Video
Published 2020

Related

LEAVO Trial - Comparison of Anti-VEGF drugs for Macular Edema Secondary to CRVO- Dr. Philip Hykin
Keyvan Koushan, MD, FRCSC
Member Podcasts
2020
Outcomes of Patients with DME and Baseline BCVA 20/50 or Worse or 20/40 or Better Treated with Aflibercept 8 mg and 2 mg in the Phase 2/3 PHOTON Trial
Diana V Do, MD, FASRS
Updates from the Field
2024
Diabetic Retinopathy 1 Symposium
Annual Meeting Talks
2020

Category: Diabetic Retinopathy

See more